# Safety Study of ProQuad® rHA in Infants (V221-037)

> **NCT00560755** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 3388 (actual)

## Conditions studied

- Measles
- Mumps
- Rubella
- Varicella

## Interventions

- **BIOLOGICAL:** ProQuad®

## Key facts

- **NCT ID:** NCT00560755
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-24
- **Primary completion:** 2008-11-24
- **Final completion:** 2008-11-24
- **Target enrollment:** 3388 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560755, "Safety Study of ProQuad® rHA in Infants (V221-037)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00560755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*